Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

2000 Biological New Drug Application (NDA) Approvals

This list reflects information regarding the application as of the approval date; it is not updated with regard to applicant or application status changes.

Established Name
Indication for Use Applicant Approval Date
Anticoagulant Sodium Citrate 4% w/v Solution, USP
Use only with automated apheresis devices in the collection of human plasma or in performing therapeutic plasma exchange procedures Haemonetics Corp
400 Wood Road
Braintree, MA 02184

Page Last Updated: 04/09/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English